Inventaire - teman dan komunitas anda adalah perpustakaan terbaik

The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Onco

pengarang

George Fountzilas

Christos Christodoulou

diterbitkan dalam: Breast Cancer Research

tanggal publikasi: 2012-11-12

subyek utama: endotelium, Kanker payudara

Cites articles 58

Date

Judul

Pengarang

2012-01-27

Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer
2012-01-01

Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.

Carsten Denkert, Peter A. Fasching, Sibylle Loibl, Michael Untch
2012-05-07

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial

Paul Delmar, Atsushi Ohtsu
2011-03-01

Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer

Wilko Weichert, Manfred Dietel
2011-02-12

Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial

Christopher Poremba
2011-01-11

Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer

Adrian Harris, Kathy D. Miller, Hope Rugo
2011-09-08

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri

Mattheos Bobos, George Fountzilas
2011-03-09

Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.

Mattheos Bobos, George Fountzilas, Ralph M Wirtz, Anastasia G Eleftheraki, Dimitrios Pectasides, Angelos Koutras, George Pentheroudakis, Konstantine T Kalogeras, Helen Gogas, Nicholas Pavlidis, Anna Batistatou, Evangelos Bournakis
2011-04-27

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation

Mattheos Bobos, Anastasia G Eleftheraki, Konstantinos Markou
2011-11-04

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study
2010-12-28

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy

Tadeusz Pieńkowski, Wolfgang Eiermann, Marc Buyse, Valerie Bee, Isabelle Tabah-Fisch, Leslie Bernstein, Michael F Press, Henry Taupin, Dennis Slamon, Angela Barreto Santiago Santos, Ivonne E Villalobos, Guido Sauter
2010-04-19

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Antonio C. Wolff, Patrick L. Fitzgibbons, Anthony Rhodes, Fred Sweep, Daniel W Visscher
2010-02-05

Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up

Karin Jirström, Olle Stål
2010-05-17

Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer

Joanne L Blum
2009-11-22

Bevacizumab in the treatment of breast cancer

George Fountzilas
2009-10-08

Use of archived specimens in evaluation of prognostic and predictive biomarkers
2009-07-17

RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods

Christopher Poremba
2009-11-25

HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer

Michael Gnant, Dietmar Tamandl, Gerd Jomrich
2009-06-23

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer

Janne Lehtiö, Barbro K Linderholm
2008-01-13

Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer
2008-09-15

Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing.

Peter Van Loo, Marie-Rose Christiaens, Patrick Neven
2008-05-27

Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer

Barbro K Linderholm, Sofia Gruvberger, Per-Uno Malmström
2007-01-01

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Marc van de Vijver, Gail H. Vance, Edith A. Perez
2007-05-01

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system
2007-09-01

Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer
2006-09-01

Molecular classification of breast cancer: limitations and potential
2006-04-01

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.

Athanasios Dimopoulos, Christos Markopoulos, George Fountzilas, Savvas Papadopoulos, Helen Gogas, Dimitrios Pectasides, Dimosthenis Skarlos, Ioannis Kostopoulos, Chrisoula D Scopa
2006-12-05

The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma
2005-05-01

Vascular endothelial growth factor mRNA levels quantified by reverse transcription-polymerase chain reaction in microdissected breast carcinoma tissues are correlated with histological type and grade of both invasive and intraductal components

Hitoshi Tsuda, Osamu Matsubara
2005-02-01

Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
2005-01-01

Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.

Cynthia B Cohen
2005-09-07

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.

Athanasios Dimopoulos, H P Kalofonos, George Fountzilas, Christos Markopoulos

Artikel - wd:Q33739381

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut